Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wendan is a Traditional Chinese Medicine (TCM) formulation, often administered as a tablet or decoction, primarily used to treat disorders associated with phlegm-heat internal disturbance syndrome. Developed and studied by institutions like Xiyuan Hospital of the China Academy of Chinese Medical Sciences, it is being evaluated for the treatment of mild to moderate generalized anxiety disorder (GAD). The formula typically contains ingredients such as *Bambusae Caulis in Taeniam* (Zhu Ru), *Aurantii Fructus Immaturus* (Zhi Shi), and *Pinelliae Rhizoma* (Ban Xia). Its mechanism of action involves regulating Qi, resolving phlegm, and clearing heat from the gallbladder and stomach to alleviate symptoms of restlessness, insomnia, and anxiety.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wendan.